Related Experiment Video
Updated: Aug 11, 2025

07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
6.9K
Metastasising Pleomorphic Adenoma: A Rare Entity.
Daphne Fonseca1, Sahithi Shilpa Arya1, Suseela Kodandapani1
1Present Address: Department of Pathology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana State 500034 India.
Summary
Metastasizing pleomorphic adenoma (MPA) is a rare salivary gland cancer subtype. This case highlights MPA development in lymph nodes after multiple recurrences of pleomorphic adenoma.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Pleomorphic adenoma (PA) is the most common benign salivary gland tumor.
- Metastasizing pleomorphic adenoma (MPA) is a rare, aggressive subtype.
- MPA often arises after multiple recurrences of primary PA.
Purpose of the Study:
- To report a rare case of metastasizing pleomorphic adenoma.
- To emphasize the diagnostic and management challenges of MPA.
- To review the clinical course of PA with recurrent disease.
Main Methods:
- Case report of a 29-year-old female patient.
- Review of clinical history including prior parotidectomy and recurrences.
- Histopathological evaluation of the primary tumor and metastatic lesions.
Main Results:
- The patient presented with MPA involving ipsilateral lymph nodes.
- The MPA was histologically indistinguishable from the primary PA.
- The development of MPA occurred after 15 years and multiple recurrences of PA.
Conclusions:
- Metastasizing pleomorphic adenoma is a rare but significant clinical entity.
- Recurrent pleomorphic adenoma warrants close monitoring for potential malignant transformation.
- Early recognition and appropriate management are crucial for improving outcomes in MPA.
Related Concept Videos
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancers Originate from Somatic Mutations in a Single Cell
12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K

